Pfizer on Tuesday affirmed its full-year 2024 projections and issued 2025 revenue and adjusted profit guidance in line with analysts' estimates. The drugmaker expects revenue from $61 billion to $ ...

The company’s Q1 2025 results ... at the midpoint. This outlook is supported by Pfizer’s strong financial health, with InvestingPro data showing a robust gross profit margin of 74.4% and ...

Pfizer (NYSE:PFE) announced robust sales for the antifungal drug Cresemba in partnership with Basilea Pharmaceutica Ltd, ...

Pfizer offers a dividend yield over 7%, but it's payout probably won't rise very fast in the decade ahead. Investors seeking ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional ...

Amgen is no exception to this dynamic. Although 2017's Tax Cuts and Jobs Act spurred the company to build a handful of new manufacturing sites within the U.S., it's still heavily reliant on its ...

The positive trend continued in the first quarter of 2025 ... end of 2027. Pfizer’s significant cost-reduction and efforts to improve R&D productivity measures should drive profit growth.

Fintel reports that on June 2, 2025, Leerink Partners downgraded their outlook for Arvinas (NasdaqGS:ARVN) from Outperform to ...

Markets closed lower on Friday, but a slew of corporate earnings and major developments across telecom, pharma, auto, and defence sectors are likely to drive action today. From Vodafone Idea’s Supreme ...

Full-year 2025 corporate profits for the S&P 500 are seen rising +9.4% ... is up more than +2% after Citigroup upgraded the stock to buy from neutral with a price target of $68. Pfizer (PFE) is up ...

Full-year 2025 corporate profits for the S&P 500 are seen rising +9.4% ... is up more than +2% after TD Cowen raised its price target on the stock to $175 from $150. Pfizer (PFE) is up more than +2% ...

The drug candidate, trevogrumab, in combination with Novo Nordisk's popular obesity drug Wegovy, chemically known as semaglutide, helped patients preserve muscle and increase fat loss in patients, ...